SCHEMBL5599389

SCHEMBL5599389

O=C(c1ccccc1Cl)N1c2ccc(F)cc2C2(CCNCC2)C1CC1CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNRHR P30968 2/20 0.40
KCNH2 Q12809 1/20 0.40
RXFP1 Q9HBX9 1/20 0.38
HSD11B1 P28845 1/20 0.37
CRHR1 P34998 2/20 0.37
CHRM1 P11229 4/20 0.36
CHRM2 P08172 1/20 0.35
CHRM3 P20309 1/20 0.35
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTR2B P41595 1/20 0.34
MAPK14 Q16539 1/20 0.34
PDK1 Q15118 3/20 0.34
PDK2 Q15119 3/20 0.34
PDK3 Q15120 3/20 0.34
PDK4 Q16654 3/20 0.34
P2RX7 Q99572 1/20 0.34
PSEN1 P49768 2/20 0.33
PSEN2 P49810 2/20 0.33
APH1B Q8WW43 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5599374 1.00 GNRHR (0.40) GNRHRKCNH2RXFP1HSD11B1CRHR1
SCHEMBL5782306 0.91 HTR2A (0.40) GNRHRKCNH2HSD11B1CYP2C9CYP2C19
SCHEMBL5782925 0.87 LMNA (0.39) HSD11B1CYP2C9CYP2C19MAPK14
SCHEMBL5600002 0.87 P2RX7 (0.37) GNRHRKCNH2CRHR1CHRM1CYP2C19
SCHEMBL5599358 0.87 PARP1 (0.36) GNRHRKCNH2CRHR1CHRM1PDK1
SCHEMBL5783985 0.87 DPP4 (0.34) GNRHRKCNH2CRHR1PDK1PDK2
SCHEMBL5599096 0.86 GNRHR (0.41) GNRHRKCNH2RXFP1HSD11B1PDK1
SCHEMBL5786887 0.86 GNRHR (0.41) GNRHRKCNH2RXFP1HSD11B1CRHR1
SCHEMBL5599203 0.85 GNRHR (0.39) GNRHRKCNH2RXFP1HSD11B1CYP2C9
SCHEMBL5600630 0.85 GNRHR (0.36) GNRHRKCNH2CRHR1CHRM1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005063745-A9 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARM INC (US) 2007-02-01 WO claimed